Page 13 - Accelerate Diagnostics News Today

Healthcare

Of the 30 companies in the index, 17 saw declines in their stock prices, while 13 saw share price increases.

The difference between growth and value funds was stark.

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, today announced the launch of the Accelerate Arc system, comprised of the Arc Module and BC Kit, an automated path to rapid and accurate ...

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of...

Analysts predict that Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Rating) will announce $3.12 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Accelerate Diagnostics’ earnings, with the lowest sales estimate coming in at $2.90 million and the highest estimate coming in at $3.33 million. Accelerate Diagnostics […]

APPLYING FUNDAMENTAL CONCEPTS OF ANTIMICROBIAL STEWARDSHIP IN ERA OF COVID-19·         Webinar on March 17, 2022, 12PM PT / 3PM ET reviews the impact of COVID-19 on the rise of antimicrobial resistance and other healthcare-related outcomesTUCSON, Ariz., March 12, 2...

Healthcare

TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Tuesday reported a loss of...

TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Tuesday reported a loss of...